News for 'All India Manufacturers Organisation'

6 out of 10 cos adopted WFH policy post Covid relaxations

6 out of 10 cos adopted WFH policy post Covid relaxations

Rediff.com29 Nov 2021

As the pandemic pushed employers to explore and adapt new ways to stay in the business, a survey has revealed that 6 out of 10 organisations have adopted 'work from home' policy post Covid-19 relaxations. Over 65 per cent of the employers have either introduced 'work from home' as a policy or are evaluating the same reflecting a maturity and the confidence in their employees, according to a survey by Grant Thornton Bharat. The survey was conducted online by Grant Thornton Bharat among 4,650 respondents across social media platforms.

Consumer durables may see double digit growth in 2022

Consumer durables may see double digit growth in 2022

Rediff.com21 Dec 2021

The industry is expecting double-digit growth on a year-on-year basis, helped by a possible price correction after softening of raw material inputs and factors such as positive sentiments, pent up demand and improving economic conditions. Besides, a shift in consumer behaviour from price consciousness towards technologically advanced premium products with quality, value proposition and safety aspects leading to a rise in demand for home automation products is making the industry upbeat. With the government's production linked incentive (PLI) scheme for white goods, which has witnessed a committed investment of Rs 4,614 crore, in place, many manufacturers are gearing up to make the most out of the opportunity as well as take steps towards reducing their dependency on imports and make products more affordable.

France offers India world's top torpedoes

France offers India world's top torpedoes

Rediff.com5 Jun 2021

'The F-21's capabilities far exceed all other torpedoes currently in service.'

What is the future of e-pharmacies in India?

What is the future of e-pharmacies in India?

Rediff.com19 Dec 2019

PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.

India impacted by global recession, will emerge from it, says Rajnath Singh

India impacted by global recession, will emerge from it, says Rajnath Singh

Rediff.com17 Dec 2019

Rajnath Singh outlined the major measures and initiatives taken by the Modi government to provide basic needs to people of India, including providing homes, building toilets to end open defecation, electricity, cooking gas and focusing on infrastructure development.

Mutual vaccine recognition eases international travel: Modi

Mutual vaccine recognition eases international travel: Modi

Rediff.com23 Sep 2021

Prime Minister Narendra Modi said on Wednesday that international travel should be made easier through mutual recognition of vaccine certificates, amid several countries adopting different sets of rules to allow foreigners to enter their territory in the wake of the COVID-19 pandemic.

Govt dismantling India's environment rules: Sonia

Govt dismantling India's environment rules: Sonia

Rediff.com13 Aug 2020

The draft environment impact assessment (EIA) notification, 2020, which involves the procedure of issuing environmental clearances to various projects, was issued by the Environment Ministry in March this year and has received thousands of suggestions from the public.

'Decisive turning point': PM hails approval to vaccines

'Decisive turning point': PM hails approval to vaccines

Rediff.com3 Jan 2021

In a series of tweets after the Drugs Controller General of India (DCGI) approved Oxford's vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use, Modi said it will make every Indian proud that both the vaccines are made in India.

WHO reminds Serum Institute of COVAX commitments

WHO reminds Serum Institute of COVAX commitments

Rediff.com18 May 2021

COVAX, 'the global COVID vaccine equity scheme', has so far delivered 65 million doses to 124 countries and economies but it is dependent on countries and manufacturers honouring their commitments.

Serum Institute seeks regular marketing approval for Covishield

Serum Institute seeks regular marketing approval for Covishield

Rediff.com25 Oct 2021

If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval.

SC asks Kerala HC to reconsider pre-arrest bail pleas in ISRO case

SC asks Kerala HC to reconsider pre-arrest bail pleas in ISRO case

Rediff.com28 Nov 2022

The Supreme Court said on Monday it will ask the Kerala high court to consider afresh the anticipatory bail pleas of four people, including a former director general of police (DGP), in a case of alleged frame-up of scientist Nambi Narayanan in the 1994 ISRO espionage matter.

WHO to decide next week on approval to Covaxin

WHO to decide next week on approval to Covaxin

Rediff.com5 Oct 2021

'WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin,' the global health body tweeted.

Rajasthan Congress fully united, disunity in BJP: Pilot

Rajasthan Congress fully united, disunity in BJP: Pilot

Rediff.com4 Dec 2022

'There may be some planted stories here or there, people trying to create manufactured controversies but the party is fully united. We will make sure the yatra is even more successful than it has been in other states'

British firm to invest up to Rs 1,925 cr in Mahindra's EV biz

British firm to invest up to Rs 1,925 cr in Mahindra's EV biz

Rediff.com8 Jul 2022

Mahindra & Mahindra (M&M) and the British International Investment (BII) have inked a pact to invest Rs 1,925 crore each in a wholly-owned subsidiary of the home-grown auto major to focus on four-wheel passenger electric vehicles. The Mumbai-based automaker and BII have executed a binding agreement to invest in the new entity -- "EV Co". According to the pact, BII will invest up to Rs 1,925 crore in the form of compulsory convertible instruments at a valuation of up to Rs 70,070 crore, resulting in 2.75 per cent to 4.76 per cent ownership in the EV Co, M&M said in a regulatory filing. EV Co will focus on four-wheel (4W) passenger electric vehicles, it added.

Pfizer tells India its vaccine 'highly effective' on Covid variant

Pfizer tells India its vaccine 'highly effective' on Covid variant

Rediff.com26 May 2021

Providing data, it said UK's Public Health England has reported high vaccine effectiveness (87.9 per cent) against the B.1.617.2 variant, most reported in India, in an observational study (concluded on May 22, 2021).

'Whatever the government says, take with ton of salt!'

'Whatever the government says, take with ton of salt!'

Rediff.com18 Aug 2022

'The prospects for both India and the global economy is that we are headed towards a very difficult time.' 'I see very uncertain at least 8-10 months for both India and the rest of the world.'

Charge officers sitting over vaccine production with manslaughter: HC

Charge officers sitting over vaccine production with manslaughter: HC

Rediff.com2 Jun 2021

Officers sitting over untapped potential to make COVID-19 vaccines need to be charged with 'manslaughter' as it is leading to so many deaths, the Delhi high court said on Wednesday, observing that a lot of scope and infrastructure is available in India which is not being used.

COVID-19 Vaccine: 4 months from lab to jab

COVID-19 Vaccine: 4 months from lab to jab

Rediff.com8 Jun 2021

'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'

FMCG distributors call off stir against Colgate after talks

FMCG distributors call off stir against Colgate after talks

Rediff.com6 Jan 2022

FMCG distributors on Thursday said it has suspended their boycott of certain products of oral care maker Colgate after talks with the company representatives over the issue of the price disparity between the traditional distributors and organised business-to-business channel. A day after a virtual meeting with Colgate-Palmolive (India) Ltd (CPIL) representatives, the All India Consumer Products Distributors Federation (AICPDF) called off its stir to boycott certain products of the company starting from January 1, 2022. "From today, the movement against Colgate is postponed till further notice," the AICPDF said in a statement.

Full disclosure of veg/non-veg food a must, affects fundamental rights: HC

Full disclosure of veg/non-veg food a must, affects fundamental rights: HC

Rediff.com2 Mar 2022

The high court directed the Food Safety and Standards Authority of India (FSSAI) to issue a fresh communication to all the authorities concerned stating the obligation to make clear disclosure as to whether the food article is vegetarian or non-vegetarian.

Security scare: 50,000 illegal drones in India!

Security scare: 50,000 illegal drones in India!

Rediff.com8 Jan 2019

The recent drone scare at London's Gatwick airport has exposed the lack of preparedness against drones, says Pranjal Sharma.

How India can meet its job creation challenge

How India can meet its job creation challenge

Rediff.com28 Dec 2017

How soon can India reach a point when there is no hidden underemployment and all who want work can find it at a fair wage and decent work conditions, asks Nitin Desai.

Bharat Biotech's Covaxin vaccine cleared by special panel

Bharat Biotech's Covaxin vaccine cleared by special panel

Rediff.com2 Jan 2021

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.

Real estate, travel and tourism blues hit India's consumption story

Real estate, travel and tourism blues hit India's consumption story

Rediff.com15 Mar 2021

India's Rs 4.5-trillion fast-moving consumer goods (FMCG) sector was one of the first to bounce back from the lockdown induced blues, reporting a year-on-year (YoY) growth in the October-December quarter last year. That said, the overall consumption figures continue to remain depressed. The FMCG market, which includes daily consumables like branded atta, hand sanitizers, edible oils, shampoos, razors, and so on, recorded 7.3 per cent value growth during the period, while the smartphone market grew by 21 per cent.

Covaxin shelf life extended, Bharat Biotech relabels old stocks

Covaxin shelf life extended, Bharat Biotech relabels old stocks

Rediff.com5 Jan 2022

The company had in December said that the CDSCO had approved a 12-month shelf life for Covaxin, which was nine months earlier, Sohini Das reports.

Modiji, Do You Have A Plan To Improve Education?

Modiji, Do You Have A Plan To Improve Education?

Rediff.com30 Jan 2023

When was the last time we heard this government speaking of the disaster in primary education, rather than Ganga cruises and cheetahs? Less money -- Rs 88,000 crore -- was spent by the Union government on education in its last Budget than has been allocated to the Bullet train, notes Aakar Patel.

The Mask India Project's success story

The Mask India Project's success story

Rediff.com24 Jun 2021

'The heart is to honour all who have been struck by Covid and the map signifies that as a country, we can win this together.'

How Nokia is riding the 5G wave in India

How Nokia is riding the 5G wave in India

Rediff.com22 Feb 2019

Nokia, that has already begun manufacturing of 5G equipment at its Chennai plant, is also readying for exporting the products to several key markets like the US.

WHO seeks 'additional clarifications' from Bharat Biotech

WHO seeks 'additional clarifications' from Bharat Biotech

Rediff.com27 Oct 2021

The technical advisory group will now meet on November 3 for a final assessment.

High crude oil price is a cause for concern: CEA

High crude oil price is a cause for concern: CEA

Rediff.com24 Feb 2022

The banking sector in the country is stable, capital is available and credit offtake is poised to take off, he said at a webinar organised by Bharat Chamber of Commerce. "We are not unique to the phenomenon of uncertain growth and high inflation due to the pandemic.

Can Modi 'develop' India by 2022?

Can Modi 'develop' India by 2022?

Rediff.com31 Oct 2017

'The Make in India target of getting manufacturing to account for 25% of GDP by 2022 is quite impossible to achieve.' 'As for the role of technology in the average Indian's life, it is still quite basic -- mobile phones and Mars successes notwithstanding,' says T N Ninan.

Employment in 9 sectors at 3.08 cr in April-June

Employment in 9 sectors at 3.08 cr in April-June

Rediff.com27 Sep 2021

Employment in nine selected sectors, including construction, manufacturing and IT/BPO, was at 3.08 crore in the April-June quarter of 2021-22, reflecting a growth of 29 per cent compared to 2.37 crore reported in the Economic Census of 2013-14, according to a survey. Labour and Employment Minister Bhupender Yadav on Monday released the report of Quarterly Employment Survey (QES) part (April to June 2021), of the All-India Quarterly Establishment-based Employment Survey (AQEES) prepared by the Labour Bureau. Announcing the results, Yadav said the estimated total employment in the nine selected sectors from the first round of QES is 3 crore and 8 lakh approximately against a total of 2 crore and 37 lakhs in these sectors taken collectively, as reported in the sixth Economic Census (EC 2013-14) reflecting a growth rate of 29 per cent.

Govt panel recommends regular market approval for Covishield, Covaxin

Govt panel recommends regular market approval for Covishield, Covaxin

Rediff.com20 Jan 2022

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain conditions, official sources said.

Despite controversies India sees widespread use of HCQ

Despite controversies India sees widespread use of HCQ

Rediff.com9 Jun 2020

Once touted as a 'wonder drug', HCQ has been battling global controversies around its safety and efficacy as a prophylactic against the new coronavirus SARS-CoV-2.

NO sanitary pads! Hygiene risks during COVID-19

NO sanitary pads! Hygiene risks during COVID-19

Rediff.com29 May 2020

With schools closing down, many girls and their female family members in rural and urban areas now don't have access to sanitary pads.

'We are on week to week business planning'

'We are on week to week business planning'

Rediff.com25 Jun 2021

'The fundamentals look strong, but we will have to see if they translate into actual demand.' 'Because the April-May marriage season didn't see much sales due to the lockdown.'

US companies seek 'fair play' in India

US companies seek 'fair play' in India

Rediff.com2 Feb 2017

Businesses in the US continue to face an evolving array of tariff and non-tariff barriers.

Court humare kabze mein...: Shah on CBI, ED 'misuse'

Court humare kabze mein...: Shah on CBI, ED 'misuse'

Rediff.com14 Feb 2023

Shah said that the people of the country will decide about the principal opposition party to BJP in the 2024 polls and they have not given this label to any party.

India-born Arvind Krishna elected CEO of IBM

India-born Arvind Krishna elected CEO of IBM

Rediff.com31 Jan 2020

Krishna's appointment as head of the global IT giant adds to the growing list of Indian-origin executives at the helm of some of the biggest multinational companies. Krishna joins the club that includes Microsoft CEO Satya Nadella, Google and Alphabet CEO Sundar Pichai, MasterCard CEO Ajay Banga, PepsiCo's former CEO Indra Nooyi and Adobe CEO Shantanu Narayen.